Allergic Rhinitis Clinical Trials

31 recruiting

Allergic Rhinitis Trials at a Glance

39 actively recruiting trials for allergic rhinitis are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 14 trials, with the heaviest enrollment activity in Beijing, Wuhan, and Hangzhou. Lead sponsors running allergic rhinitis studies include Universitaire Ziekenhuizen KU Leuven, Antalya Training and Research Hospital, and Alixer Nexgen Therapeutics Limited.

Browse allergic rhinitis trials by phase

Treatments under study

About Allergic Rhinitis Clinical Trials

Looking for clinical trials for Allergic Rhinitis? There are currently 31 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Allergic Rhinitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Allergic Rhinitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 39 trials

Recruiting

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

Seasonal Allergic RhinitisPerennial Allergic RhinitisLocal Allergic Rhinitis
Universitaire Ziekenhuizen KU Leuven200 enrolled2 locationsNCT04544774
Recruiting
Phase 3

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

Perennial Allergic Rhinitis (PAR)
Eli Lilly and Company450 enrolled77 locationsNCT06339008
Recruiting
Phase 2

Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.300 enrolled30 locationsNCT07398859
Recruiting
Not Applicable

Dietary Intervention on Atopy

Atopic DermatitisAllergic DiseasesAllergic Rhinitis+1 more
National University of Singapore110 enrolled1 locationNCT06547372
Recruiting
Not Applicable

Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project

Allergic Rhinitis
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa880 enrolled1 locationNCT07419230
Recruiting
Not Applicable

Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children

AnxietyAsthma (Diagnosis)Allergic Rhinitis+1 more
Antalya Training and Research Hospital100 enrolled1 locationNCT07453615
Recruiting
Phase 1Phase 2

Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma

Allergic AsthmaAllergic Rhinitis
University of Zurich36 enrolled1 locationNCT06960382
Recruiting

The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis for Dust Mite Allergens in Chinese Pediatric Patients With Rhinitis and/or Asthma

Allergic Rhinitis Due to House Dust Mite
The Children's Hospital of Zhejiang University School of Medicine1,000 enrolled1 locationNCT07452380
Recruiting
Not Applicable

Validation of an Allergic Rhinitis Control Test in Children

Allergic Rhinitis
University Hospital, Montpellier135 enrolled6 locationsNCT03075917
Recruiting
Phase 3

A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65

Allergic RhinitisAllergic Rhinoconjunctivitis
ALK-Abelló A/S300 enrolled30 locationsNCT07060885
Recruiting

Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations

Allergic Rhinitis
University Hospital, Strasbourg, France30 enrolled1 locationNCT07315945
Recruiting

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a
National Institute of Allergy and Infectious Diseases (NIAID)10,000 enrolled1 locationNCT06732414
Recruiting
Not Applicable

Investigation of the Effects of a Multispecies Probiotic Formulation on Perennial Allergic Rhinitis

Perennial Allergic Rhinitis
Winclove B.V.98 enrolled1 locationNCT07157462
Recruiting
Phase 2

A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure

Seasonal Allergic Rhinitis (SAR)
Alixer Nexgen Therapeutics Limited164 enrolled1 locationNCT07219849
Recruiting
Phase 2

Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Beijing Tongren Hospital120 enrolled1 locationNCT06300203
Recruiting
Phase 3

Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma

Perennial Allergic Rhinitis Accompanied by Asthma
Daewon Pharmaceutical Co., Ltd.274 enrolled1 locationNCT07168473
Recruiting
Phase 2

A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Guangdong Hengrui Pharmaceutical Co., Ltd100 enrolled1 locationNCT07091357
Recruiting
Not Applicable

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Allergic AsthmaAsthma AcuteThunderstorm Asthma+3 more
University of Melbourne530 enrolled1 locationNCT07055542
Recruiting
Phase 3

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis

Allergic Rhinitis, Seasonal
Genrix (Shanghai) Biopharmaceutical Co., Ltd.150 enrolled1 locationNCT07154342
Recruiting
Not Applicable

Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis

Allergic RhinitisAllergic Rhinitis (AR)
Tanta University120 enrolled1 locationNCT07115342